English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Vimbai Chikomo | Feb 7, 2017

Small businesses air ACA grievances to House panel

Keri Carbaugh | Feb 7, 2017

Heart association applauds latest assault on salt

Keri Carbaugh | Feb 7, 2017

Non-browning apples might take bite out of GMO fears

Keri Carbaugh | Feb 7, 2017

Sonoco raises price on some recycled products

Tabitha Fleming | Feb 7, 2017

Brown M&Ms offer lesson for graying population

John Breslin | Feb 6, 2017

GOP look to ease ACA burden ahead of major reform

Keri Carbaugh | Feb 6, 2017

Shire takes lead on rare conditions, CEO says

John Breslin | Feb 6, 2017

Obamacare criticized as more harm than help

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones

  • « First
  • «
  • …
  • 406
  • 407
  • 408
  • 409
  • 410
  • 411
  • 412
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily